Craft

PeptiDream

Stock Price

¥2.8 K

2024-10-28

Market Capitalization

¥367.7 B

2024-10-28

Revenue

¥18.5 B

FY, 2025

PeptiDream Summary

Company Summary

Overview
PeptiDream (ペプチドリーム) is a biopharmaceutical company specializing in drug discovery and development. It offers a discovery platform that enables the production of diverse non-standard peptide libraries for the identification of potent and selective hit candidates.
Type
Public
Status
Active
Founded
2006
HQ
Kawasaki, JP | view all locations
Website
https://www.peptidream.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Patrick Reid, Representative Director, President

    • Keiichi Masuya, Executive Vice President Director – Board Member

      LocationsView all

      2 locations detected

      • Kawasaki, Kanagawa HQ

        Japan

        3-25-23 Tonomachi

      • Tokyo, Tokyo

        Japan

        TOYO Bldg., 6F, 1-2-10, Nihonbashi, Chuo-ku

      PeptiDream Financials

      Summary Financials

      Revenue (FY, 2025)
      ¥18.5B
      Gross profit (FY, 2025)
      ¥9.3B
      Net income (FY, 2025)
      (¥3.7B)
      Cash (FY, 2025)
      ¥28.7B
      EBIT (FY, 2025)
      (¥5.1B)
      Enterprise value
      $356.5B

      Footer menu